This specific tumor combination has been reported in very few cases. The patient was a 41-year-old woman who came to the hospital with lower abdominal pain and swelling that had persisted for ...

The charity event will start at 1 p.m. on April 27 with proceeds going to the Glenn Garcelon Foundation, which raises money to provide financial support for brain tumor patients and their families.

The TKI zongertinib is currently being reviewed by the FDA for a potential approval for patients with HER2 mutation–positive non–small cell lung cancer. The HER2-selective TKI zongertinib was safe and ...

"The characteristics of NET vary widely from patient to patient ... Clinical Director of the Gastrointestinal Cancer Center and Director of the Program in Carcinoid and Neuroendocrine Tumors ...

Research led at Dana-Farber in Boston by Jennifer Chan, MD, MPH, supports an FDA approval for cabozantinib for previously treated patients with advanced neuroendocrine tumors. Boston ...

The study, conducted using induced pluripotent stem cell (iPSC)-derived motor neurons from a single patient with ALS, demonstrated that edaravone significantly reduced the abnormal cytoplasmic ...

Angus Chen covers all issues broadly related to cancer including drugs ... Research Programs (CDMRP), for which his consortium of patient and provider groups advocates. “No money for kidney ...